CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


Moderna Inc 's Pre-Tax Profit Margin by quarter

Trends, Rankings, Statistics



MRNA Pre-Tax Profit Margin (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Revenue Change 6462.07 % 22989.76 % 431893.13 % 309527.45 % 100431.82 %
Seq. Revenue Change 124.78 % 239.38 % 261.44 % 137.99 % 690.93 %
Revenue In Millions $4,354.00 $1,937.00 $570.75 $157.91 $66.35
Pre-Tax Profit Margin 70.35 % 65.05 % - - -
Pre-Tax Profit Margin Total Ranking # 170 # 158 # # #
Pre-Tax Income In Millions $3,063.00 $1,260.00 $-271.01 $-232.77 $-116.57
Y / Y Pre-Tax Income Change - - - - -
Seq. Pre-Tax Income Change 143.1 % - - - -


Commenting Second Quarter 2021 Pre-Tax Profit Margin
Moderna Inc Pre-Tax Income grew by 143.1 % in II. Quarter sequntially to 3,063 millions, while Revenue increased by 124.78 %, this led to improvement in Company's Pre-Tax Profit Margin to 70.35 %, Pre-Tax Profit Margin remained below Moderna Inc average.

Observing second quarter 2021 results within Biotechnology & Drugs industry 2 other companies have achieved higher Pre-Tax Profit Margin. While Pre-Tax Profit Margin overall ranking has deteriorated compare to previous quarter from 158 to 170.

MRNA's Pre-Tax Profit Margin second quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 3
Healthcare Sector # 16
Overall # 170

Pre-Tax Profit Margin Statistics
High Average Low
961.25 % 358.02 % 65.05 %
(Sep 30 2015)   (Mar 31 2021)




Other Pre-Tax Profit Margin Profitability Ratios
MRNA's Cumulative Pre-Tax Profit Margin
Biotechnology & Drugs Industry Pre-Tax Profit Margin Trends and Statistics
Healthcare Sector Pre-Tax Profit Margin Statistics
Pre-Tax Profit Margin Profitability Trends for overall market
MRNA's Pre-Tax Profit Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Pre-Tax Profit Margin
Lowest Ranking Pre-Tax Profit Margin
Pre-Tax Profit Margin Profit Margin for MRNA's Competitors
Pre-Tax Profit Margin Profit Margin for Moderna Inc 's Suppliers
Pre-Tax Profit Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Pre-Tax Income Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar Pre-Tax Profit Margin in the quarter ending Jun 30 2021, within Biotechnology & Drugs Industry Pre-Tax Profit MarginJun 30 2021 MRQ Pre-Tax IncomeJun 30 2021 MRQ Revenue
Royalty Pharma Plc  145.37 %$ 806.755 $ 554.963 
Crispr Therapeutics Ag  84.75 %$ 763.368 $ 900.701 
Moderna Inc   70.35 %$ 3,063.000 $ 4,354.000 
Halozyme Therapeutics Inc   67.07 %$ 91.516 $ 136.455 
Fulgent Genetics Inc   64.77 %$ 99.502 $ 153.616 
Iterum Therapeutics Plc  50.15 %$ 7.920 $ 15.794 
Vir Biotechnology Inc   34.94 %$ 61.866 $ 177.068 
Amyris Inc   31.81 %$ 16.644 $ 52.316 
Gilead Sciences Inc   29.23 %$ 1,817.000 $ 6,217.000 
Tarsus Pharmaceuticals Inc   28.69 %$ 6.316 $ 22.017 
Repligen Corp  27.22 %$ 44.358 $ 162.960 
Cidara Therapeutics Inc   26.84 %$ 8.819 $ 32.863 
Meridian Bioscience Inc   24.08 %$ 15.295 $ 63.511 
La Jolla Pharmaceutical Company  23.25 %$ 3.733 $ 16.059 
Biogen Inc   20.98 %$ 582.100 $ 2,775.000 
Neurocrine Biosciences Inc   19.90 %$ 57.500 $ 288.900 
Integrated Biopharma Inc  17.26 %$ 2.944 $ 17.058 
Neogen Corp  15.81 %$ 20.146 $ 127.425 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EXPR's Profile

Stock Price

EXPR's Financials

Business Description

Fundamentals

Charts & Quotes

EXPR's News

Suppliers

EXPR's Competitors

Customers & Markets

Economic Indicators

EXPR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071